Dexamethasone‐Mediated Regulation of CYP3A4 and UGTs in Human Hepatoma HuH‐7 Cells
Fundamental & Clinical Pharmacology · 2026-05 · 40 (3)
DOI: 10.1111/fcp.70089 ↗At a glance
Journal article in Fundamental & Clinical Pharmacology, published online on 2026-04-21. Written by Hana Yu and 4 co-authors. Institution: College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea. Major MEDLINE topics: Dexamethasone, Glucuronosyltransferase, Cytochrome P-450 CYP3A, Carcinoma, Hepatocellular. Cited 1 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Research Foundation of Korea, Korean Government Ministry of Education, MSIT.
Abstract (original language)
Background
The application of human hepatic cell lines to early drug discovery and development instead of human primary hepatocytes (HPHs) has been limited because of the low level of drug‐metabolizing enzymes (DMEs).
Objective
The study aimed to evaluate the effects of dexamethasone (DEX) treatment on DME expression, activities, and regulation in HuH‐7 hepatoma cells.
Methods
Expression and transcriptional regulation of major CYPs and UGTs in HuH‐7 cells was evaluated by immunoblotting, probe substrate assays, and treatments with nuclear receptor agonists, including DEX, and antagonists.
Results
DEX increased the expression and activity of cytochrome P450 (CYP) 3A4, uridine 5′‐diphospho‐glucuronosyltransferase (UGT) 1A1, and UGT2B7 but had minimal effects on CYP1A2, CYP2B6, or CYP2C9. These augmented activities of CYP3A4, UGT1A1, and UGT2B7 were concentration‐dependently inhibited by their corresponding selective inhibitors. DEX‐induced upregulation of CYP3A4 protein expression was abolished by co‐treatment with the glucocorticoid receptor (GR) inhibitor, but not by co‐treatment with the pregnane X receptor (PXR) inhibitor. However, treatment with PXR or constitutive androstane receptor (CAR) agonist did not lead to transcriptional activation of CYP3A4 and 2B6. Only CYP1A1 was transactivated by an aryl hydrocarbon receptor (AhR) ligand.
Conclusion
Our results suggest that the activities of some major DMEs (CYP3A4, UGT1A1, and UGT2B7) in HuH‐7 cells are promoted by DEX treatment possibly through GR activation. However, unlike HPHs, HuH‐7 cells fail to show transcriptional regulation of DMEs by PXR or CAR, which limits their suitability for evaluating DME induction potential of investigational drugs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea.
ORCID profiles: Hee Eun Kang
Funding
- National Research Foundation of Korea
- Korean Government Ministry of Education
- MSIT
- Ministry of Science and ICT, South Korea
Cite
APA
Yu, H., Lee, S. H., Kim, J. H., Kim, S. J., & Kang, H. E. (2026). Dexamethasone‐Mediated Regulation of CYP3A4 and UGTs in Human Hepatoma HuH‐7 Cells. Fundamental & Clinical Pharmacology, 40(3). https://doi.org/10.1111/fcp.70089
Vancouver
Yu H, Lee SH, Kim JH, Kim SJ, Kang HE. Dexamethasone‐Mediated Regulation of CYP3A4 and UGTs in Human Hepatoma HuH‐7 Cells. Fundamental & Clinical Pharmacology. 2026;40(3). doi:10.1111/fcp.70089
BibTeX
@article{Yu2026,
author = {Yu, Hana and Lee, Song Hee and Kim, Ji Hyeon and Kim, Seung Jin and Kang, Hee Eun},
title = {Dexamethasone‐Mediated Regulation of CYP3A4 and UGTs in Human Hepatoma HuH‐7 Cells},
journal = {Fundamental & Clinical Pharmacology},
year = {2026},
volume = {40},
number = {3},
doi = {10.1111/fcp.70089}
}
EUVIMED